ULTRAGENYX PHARMACEUTICAL INC. - COMMON STOCK
43,65
08-января-25 16:45:00
15 мин. задержка
Акции
-0,79
-1,78%
Сегодняшний диапазон
43,28 - 44,78
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Ultragenyx to Participate in Orphan Neuro Panel at Cowen Healthcare Conference
28 фев 2023 16:01:00 Источник Nasdaq GlobeNewswire
-
Ultragenyx Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Update
16 фев 2023 16:01:00 Источник Nasdaq GlobeNewswire
-
09 фев 2023 16:01:00 Источник Nasdaq GlobeNewswire
-
06 янв 2023 16:01:00 Источник Nasdaq GlobeNewswire
-
Ultragenyx to Present at the 41st Annual J.P. Morgan Healthcare Conference
04 янв 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
21 дек 2022 16:01:00 Источник Nasdaq GlobeNewswire
-
Ultragenyx to Present at Piper Sandler Healthcare Conference
22 ноя 2022 16:01:00 Источник Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
18 ноя 2022 16:05:00 Источник Nasdaq GlobeNewswire
-
Ultragenyx Announces Departure of Chief Financial Officer
10 ноя 2022 16:15:00 Источник Nasdaq GlobeNewswire
-
Ultragenyx to Present at Upcoming Healthcare Conferences
09 ноя 2022 16:01:00 Источник Nasdaq GlobeNewswire
-
Ultragenyx Reports Third Quarter 2022 Financial Results and Corporate Update
02 ноя 2022 16:05:01 Источник Nasdaq GlobeNewswire
-
Ultragenyx to Host Conference Call for Third Quarter 2022 Financial Results and Corporate Update
27 окт 2022 16:01:00 Источник Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04 окт 2022 16:30:00 Источник Nasdaq GlobeNewswire
-
Ultragenyx and Mereo BioPharma to Present Setrusumab Data Update at ASBMR
09 сен 2022 20:22:15 Источник Nasdaq GlobeNewswire
-
Ultragenyx to Participate at Citi BioPharma Conference
01 сен 2022 16:01:00 Источник Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17 авг 2022 16:01:00 Источник Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
03 авг 2022 16:05:02 Источник Nasdaq GlobeNewswire
-
Ultragenyx Reports Second Quarter 2022 Financial Results and Corporate Update
28 июл 2022 16:01:00 Источник Nasdaq GlobeNewswire
-
Ultragenyx to Host Conference Call for Second Quarter 2022 Financial Results and Corporate Update
25 июл 2022 16:01:00 Источник Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
20 июл 2022 17:09:15 Источник Nasdaq GlobeNewswire